PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer

Adriamycin (ADM) is currently one of the most effective chemotherapeutic agents in breast cancer treatment. However, growing resistance to ADM could lead to treatment failure and poor outcome. PLAC8 was reported as a novel highly conserved protein and functioned as an oncogene or tumour suppressor i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yongxia, Jia, Yunlu, Mao, Misha, Gu, Yifeng, Xu, Chenpu, Yang, Jingjing, Hu, Wenxian, Shen, Jun, Hu, Dengdi, Chen, Cong, Li, Zhaoqing, Chen, Lini, Ruan, Jian, Shen, Peng, Zhou, Jichun, Wei, Qun, Wang, Linbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278087/
https://www.ncbi.nlm.nih.gov/pubmed/34117724
http://dx.doi.org/10.1111/jcmm.16706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278087/
https://www.ncbi.nlm.nih.gov/pubmed/34117724
http://dx.doi.org/10.1111/jcmm.16706

Ejemplares similares